Related Experiment Video
Updated: Apr 18, 2026

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
Published on: March 26, 2018
Advances in the molecular functions of syndecan-1 (SDC1/CD138) in the pathogenesis of malignancies
1Biological Sciences, State University of New York College of Old Westbury, 233 Store Hill Road, Old Westbury, NY 11568, USA.
Abstract:
Syndecan-1 (SDC1, synd, CD138) is the most widely studied member of four structurally related cell surface heparan sulfate proteoglycans (HSPG). Although SDC1 has been implicated in a wide range of biological functions, its altered expression often produces malignant phenotypes, which arise from increased cell proliferation and cell growth, cell survival, cell invasion and metastasis, and angiogenesis. Recent studies revealed much about the underlying molecular roles of SDC1 in these processes. The changes in SDC1 expression also have a direct impact on the clinical course of cancers, as evident by its prognostic significance. Accumulating evidence suggest that SDC1 is involved in stimulation of cancer stem cells (CSC) or tumor initiating cells (TIC) and this may affect disease relapse, and resistance to therapy. This review discusses the progress on the pro-tumorigenic role(s) of SDC1 and how these roles may impact the clinical aspect of the disease. Also discussed, are the current strategies for targeting SDC1 or its related signaling.
Insights
Syndecan-1 (SDC1) promotes cancer progression by enhancing cell growth, invasion, and angiogenesis. Targeting SDC1 may offer new therapeutic strategies for cancer treatment and overcoming resistance.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Syndecan-1 (SDC1), a cell surface heparan sulfate proteoglycan, is crucial for various biological functions.
- Altered SDC1 expression is linked to malignant phenotypes including increased proliferation, survival, invasion, metastasis, and angiogenesis.
Purpose of the Study:
- To review the pro-tumorigenic roles of Syndecan-1 (SDC1) in cancer.
- To discuss the impact of SDC1 on clinical cancer progression, relapse, and therapeutic resistance.
- To explore current strategies targeting SDC1 and its signaling pathways.
Main Methods:
- Literature review of recent studies on SDC1's molecular roles in cancer.
- Analysis of SDC1's prognostic significance in various cancers.
- Examination of SDC1's involvement in cancer stem cells (CSCs) and therapeutic resistance.
Main Results:
- SDC1 significantly contributes to tumor growth, invasion, metastasis, and angiogenesis.
- SDC1 expression levels correlate with clinical outcomes and prognosis in cancer patients.
- SDC1 plays a role in stimulating cancer stem cells (CSCs), potentially leading to relapse and treatment resistance.
Conclusions:
- SDC1 exhibits significant pro-tumorigenic functions across various cancers.
- SDC1's role in CSCs highlights its importance in disease relapse and therapeutic resistance.
- Targeting SDC1 presents a promising avenue for novel cancer therapies.
Related Concept Videos
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Cancer Cell Migration through Invadopodia
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved...
Cell Adhesion Molecules - Types and Functions
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Abnormal Proliferation

